🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jane W. Liang

Kaiser Permanente

ORCID: 0000-0002-2302-3809

Also affiliated with Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Multi-syndrome, multi-gene risk modeling for individuals with a family history of cancer with the novel R package PanelPRO”.

Multi-syndrome, multi-gene risk modeling for individuals with a family history of cancer with the novel R package PanelPRO

eLife(2021)10.7554/elife.68699
N/A
0DataRank · unranked
19 citations

Jane W. Liang, Qing Zhang, Theodore Huang, Christine Choirat, Giovanni Parmigiani +2 more

A framework evaluating the utility of multi-gene, multi-disease population-based panel testing that accounts for uncertainty in penetrance estimates

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.10.503415
N/A
0DataRank · unranked
0 citations

Kurt D. Christensen, Robert C. Green, Peter Kraft, Jane W. Liang

Low infectivity among asymptomatic patients with a positive severe acute respiratory coronavirus virus 2 (SARS-CoV-2) admission test at a tertiary care center, 2020–2022

Infection Control and Hospital Epidemiology(2023)10.1017/ice.2023.210
N/A
0DataRank · unranked
5 citations

Melanie Kiener, Jane W. Liang, Gustavo Contreras, Guillermo Rodríguez-Nava, Alex Zimmet +9 more

Benchmarking clinical risk prediction algorithms with ensemble machine learning: An illustration of the superlearner algorithm for the non-invasive diagnosis of liver fibrosis in non-alcoholic fatty liver disease

medRxiv(2023)10.1101/2023.08.02.23293569
N/A
0DataRank · unranked
1 citations

Jane W. Liang, Ajitha Mannalithara, Allison Kwong, Lü Tian, W. Ray Kim +1 more

Evaluating the utility of multi-gene, multi-disease population-based panel testing accounting for uncertainty in penetrance estimates

npj Genomic Medicine(2024)10.1038/s41525-024-00414-y
N/A
0DataRank · unranked
0 citations

Kurt D. Christensen, Robert C. Green, Peter Kraft, Jane W. Liang

Injectable Estradiol Use in Transgender and Gender-Diverse Individuals throughout the United States

The Journal of Clinical Endocrinology & Metabolism(2025)10.1210/clinem/dgaf015
N/A
0DataRank · unranked
6 citations

Carly E. Kelley, Erika Sullivan, Julia J Chang, Gagandeep Singh, Sarah Kokosa +26 more

Use of Intrathecal Amphotericin for Coccidioidal Meningitis

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf675
N/A
0DataRank · unranked
1 citations

Eva Gorenburg, Jane W. Liang, Guillermo Rodríguez-Nava, Vanessa El Kamari, Julie Parsonnet +1 more

Longitudinal Patient-Reported Outcome Trajectories in Long COVID: Findings From the STOP-PASC Clinical Trial

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf634
N/A
0DataRank · unranked
1 citations

Haley Hedlin, Jane W. Liang, Blake Shaw, Evan Maestri, Michelle I. Lin +5 more

A framework for the rigorous assessment of heterogeneous treatment effects from a single randomized controlled trial

American Journal of Epidemiology(2025)10.1093/aje/kwaf253
N/A
0DataRank · unranked
0 citations

Lü Tian, Manjula Kurella Tamura, Maria E. Montez‐Rath, Constantine Frangakis, Vivek Charu +1 more

Systems Immunology of Long Covid: Insights from the STOP-PASC Clinical Trial

medRxiv(2025)10.64898/2025.12.04.25341650
N/A
0DataRank · unranked
0 citations

Woo Joo Kwon, Hong Zheng, Tyler R. Prestwood, Haley Hedlin, Jane W. Liang +24 more